1. The safety of benazepril stands up to examination

   Newsletter Article 29 January 2013 Pages: 1 - 1

2. Another look at halothane hepatitis

   Newsletter Article 29 January 2013 Pages: 1 - 1

3. Is myocarditis a risk factor for anaesthesia in children?

   Newsletter Article 29 January 2013 Pages: 2 - 2

4. Antibacterial-related pseudomembranous colitis

   Newsletter Article 29 January 2013 Pages: 2 - 3

5. Aciclovir

   Newsletter Article 29 January 2013 Pages: 3 - 3

6. Amfebutamone

   Newsletter Article 29 January 2013 Pages: 3 - 3

7. Amoxicillin

   Newsletter Article 29 January 2013 Pages: 3 - 3

8. Anabolic steroid abuse

   Newsletter Article 29 January 2013 Pages: 3 - 3

9. Anaesthetics

   Newsletter Article 29 January 2013 Pages: 3 - 3

10. Antipsychotics

    Newsletter Article 29 January 2013 Pages: 3 - 3

11. BCG vaccine

    Newsletter Article 29 January 2013 Pages: 3 - 4

12. Beclomethasone

    Newsletter Article 29 January 2013 Pages: 4 - 4

13. Budesonide

    Newsletter Article 29 January 2013 Pages: 4 - 4

14. Bupivacaine

    Newsletter Article 29 January 2013 Pages: 4 - 4

15. Captopril

    Newsletter Article 29 January 2013 Pages: 4 - 4

16. Carbamazepine

    Newsletter Article 29 January 2013 Pages: 4 - 4

17. Carbamazepine interaction

    Newsletter Article 29 January 2013 Pages: 4 - 5

18. Cefaclor

    Newsletter Article 29 January 2013 Pages: 5 - 5

19. Ciprofloxacin

    Newsletter Article 29 January 2013 Pages: 5 - 5

20. Clonazepam

    Newsletter Article 29 January 2013 Pages: 5 - 5

21. Clonidine overdose

    Newsletter Article 29 January 2013 Pages: 5 - 5

22. Cocaine abuse

    Newsletter Article 29 January 2013 Pages: 5 - 5

23. Daunorubicin/doxorubicin

    Newsletter Article 29 January 2013 Pages: 5 - 5

24. Dextran 70

    Newsletter Article 29 January 2013 Pages: 5 - 6

25. Diltiazem

    Newsletter Article 29 January 2013 Pages: 6 - 6

26. Doxorubicin

    Newsletter Article 29 January 2013 Pages: 6 - 6

27. Doxorubicin see Daunorubicin/doxorubicin

    Newsletter Article 29 January 2013 Pages: 6 - 6

28. Enalapril

    Newsletter Article 29 January 2013 Pages: 6 - 6

29. Epoetin

    Newsletter Article 29 January 2013 Pages: 6 - 6

30. Etoposide

    Newsletter Article 29 January 2013 Pages: 6 - 7

31. Flumazenil

    Newsletter Article 29 January 2013 Pages: 7 - 7

32. Fluoxetine

    Newsletter Article 29 January 2013 Pages: 7 - 7

33. Fluvoxamine

    Newsletter Article 29 January 2013 Pages: 7 - 7

34. Fluvoxamine interaction

    Newsletter Article 29 January 2013 Pages: 7 - 7

35. Gamma hydroxybutyrate

    Newsletter Article 29 January 2013 Pages: 7 - 7

36. Glibenclamide see Warfarin interaction

    Newsletter Article 29 January 2013 Pages: 7 - 7

37. Gold

    Newsletter Article 29 January 2013 Pages: 8 - 8

38. Haloperidol/levomepromazine

    Newsletter Article 29 January 2013 Pages: 8 - 8

39. Herbal medicines

    Newsletter Article 29 January 2013 Pages: 8 - 8

40. Hydrocortisone

    Newsletter Article 29 January 2013 Pages: 8 - 8

41. Imipenem

    Newsletter Article 29 January 2013 Pages: 8 - 8

42. Immunoglobulin

    Newsletter Article 29 January 2013 Pages: 8 - 9

43. Immunosuppressants

    Newsletter Article 29 January 2013 Pages: 9 - 9

44. Interferon alpha 2B

    Newsletter Article 29 January 2013 Pages: 9 - 9

45. Ipratropium bromide

    Newsletter Article 29 January 2013 Pages: 9 - 9

46. Isoniazid

    Newsletter Article 29 January 2013 Pages: 9 - 9

47. Isotretinoin

    Newsletter Article 29 January 2013 Pages: 9 - 9

48. Ketanserin overdose

    Newsletter Article 29 January 2013 Pages: 9 - 10

49. Ketoconazole

    Newsletter Article 29 January 2013 Pages: 10 - 10

50. Levomepromazine see Haloperidol/levomepromazine

    Newsletter Article 29 January 2013 Pages: 10 - 10